Scholar's Cultivation System Panel

As a world-renowned international organization, the WHO's influence is absolutely unparalleled, especially in the field of health and medicine. Basically, their words represent absolute authority. In addition, Nature magazine also uses the topic of the Deep Technology Biological Research Laboratory as the cover of its new journal, and the meaning is self-evident.

From the establishment of the WHO to the present, it can be said that there are only a handful of cases where the Director-General has spared no effort to support a company's research project at a press conference.

This makes it impossible for everyone to pay attention to the new chimeric antigen receptor T cell immunotherapy.

Almost before the press conference was over, reports on relevant content had already appeared on major overseas platforms.

It triggered a new round of discussion among overseas netizens.

Originally, because Ruihui Biotech deliberately spread rumors, many people had doubts about this new technology.

I feel that the therapeutic effect is too exaggerated.

Humans are still unable to completely conquer cancer and solve this problem.

Also, this technology was not developed by a company in my own country, so I feel somewhat distrustful of it.

But it was under this situation that Tan Said came up with such a trick.

There is also proof from Nature magazine.

All telling them that this technology is real and effective.

No matter what kind of people they have, they are all equal in the face of disease.

No one wants cancer to come to them or their family.

If there was a real chance of curing cancer, they wouldn't care which company was working on it.

As long as it can be used.

If someone knows that there is such a technology to cure cancer, but still prevents them from using it, please believe that the outcome of the other party will definitely be tragic.

And this is indeed the case.

As more and more overseas netizens began to make their own judgments, the mastermind behind Ruihui Biotech was gradually uncovered, which can be said to have aroused excitement and expressed that they would no longer buy drugs produced by Ruihui in the future. This is not a good thing for Ruihui. It will undoubtedly add insult to injury.

"Even the World Health Organization and Nature magazine have expressed their opinions. It seems that this technology can indeed cure cancer."

"I have long said that Deepin Technology is a special company. How can it do things that damage its image? The effects that have been circulated must be real."

"I also saw Xu Yun's figure in the video. With this genius, there is no way it is fake."

"According to my friends in Jingzhou City, many cancers there have been successfully cured and discharged, and the cost of treatment is much lower than traditional chimeric antigen receptor T cell immunotherapy."

"It's great to be able to solve cancer and I hope this technology can be introduced sooner."

"Nature is the most authoritative scientific magazine. They prove that there is absolutely no problem."

"I asked why there are suddenly so many technical people questioning this. It turns out that the pharmaceutical company is behind it. Now it is even more impossible to use his anti-cancer drugs."

…

There are not many cancer patients overseas, and for patients who have taken anti-cancer drugs, they know very well that the cost is not a lot.

After truly seeing the advantages of the new chimeric antigen receptor T-cell immunotherapy, I believe that even if they are allowed to use anti-cancer drugs again, they will never accept or agree to it.

It can be said that from the moment the new chimeric antigen receptor T cell immunotherapy became known to everyone, the era of traditional anti-cancer drugs was declared over. No matter how many partners Ruihui Biological contacted for cooperation, it could not prevent the change and development of the situation.

Strictly speaking, Ai Bo Le had some vague guesses about the development of this matter.

I know in my heart that it is only a matter of time that the company will lose the global anti-cancer drug market sooner or later.

Because of this, he behaved relatively calmly when handing over tasks to Paina.

The expression on his face barely made any waves.

The reason why he simply accepts the changes in the market every year is because he still has hope in his heart and is unwilling to let the company lose the market just like this.

After all, the previous CEOs of the company all led the company to grow stronger.

Various special medicines have been developed.

When I got to him, it went straight downhill.

It's really hard to accept.

For this reason, when Paina accepted the task and started taking action, he stayed in his office and did nothing. He always watched the situation on the Internet to see what would happen.

When he first saw that everyone had successfully questioned the new chimeric antigen receptor T-cell immunotherapy of the Deepin Technology Biotechnology Research Laboratory, he was quite excited and felt that the situation was not without any room for maneuver for them.

As long as everyone deepens their doubts, they will be less likely to take the step to try it out later.

In this way, most cancer patients will continue to choose anti-cancer drugs.

However, the plan could not keep up with the changes. No one expected that the WHO and Nature magazine would suddenly take action at this time.

And he was still so fierce when he took action.

In an instant, the direction of the wind was reversed, completely crushing their first advantage.

At this moment, he looked at everyone's discussions on the website platform, especially when he found that some people could not wait to use this technology. He quickly realized that they had failed.

It failed completely.

He was not surprised that Nature magazine would use a topic from the Deep Technology Biological Research Laboratory as the cover of its new journal. After all, this was not the first time that they announced Xu Yun's research results.

What's more, conquering a far-reaching topic like cancer will not be let go no matter what the outcome.

After all, major medical laboratories around the world fully understand the difficulty of curing cancer.

There is a high probability that it is a waste of time and resources.

So most of the time, research is done from the perspective of treatment, without thinking about cure at all.

Therefore, there are very few experimental teams willing to choose this kind of subject.

The biological research laboratory of Deep Technology can definitely be called a special example.

But it should not be said that it is very surprising that WHO Director-General Tan Said is so supportive of the new chimeric antigen receptor T cell immunotherapy and has actively spent money to introduce this technology.

He didn't even know when the other party came into contact with the Deepin Technology Biological Research Laboratory.

Of course, things have basically become a foregone conclusion now, and nothing can be changed no matter what you say.

"I didn't expect that I would lose to a laboratory that was only established a few years ago. Are we really on the wrong track?"

Silently looking away from the computer screen, Ai BoLe turned around and looked through the floor-to-ceiling windows at the scenery behind him. He didn't know what came to his mind and muttered to himself with a lonely expression.

Deepin Technology has grown into a huge technology giant in just a few years since its establishment.

Among them, the biological research laboratory was built later.

It can be said that there is no way to compare with their Ruihui medical research laboratory.

Whether it is background or experience.

But the other party has developed a new type of chimeric antigen receptor T cell immunotherapy and announced that it can conquer cancer.

On the other hand, they have been pacing the field of anti-cancer drugs.

No attempt was made to research new cancer treatments.

From a certain point of view, it is inevitable to be surpassed today. Who knows that they do not have an existence like Xu Yun.

Fortunately, it is worth mentioning that Aibole did not immerse himself in this lonely mood for too long. After all, there are still many things left in the company that need to be solved by him as the CEO, otherwise Ruihui Biotech will really We are about to gradually withdraw from the stage.

Compared with other pharmaceutical companies, Ruihui Biotech is very large globally.

Although the anti-cancer drugs developed by Ruihui are very famous, the company's business scope is relatively wide.

Even if the market for anti-cancer drugs is lost, it does not mean that the company will not be able to continue operating.

It is nothing more than causing huge profit losses.

The most important thing is what to do next to minimize the loss as much as possible.

At the same time, we will make plans for the future development direction of the company.

The thought stayed here, and a lot of ideas could not help but flash through his mind quickly.

But just at this time, he heard a slightly urgent knock on the door from outside the office, forcing him to break away from his thinking state.

"Come in."

Ai BoLe sat down again, raised his gaze to the door and responded.

The next second, Paina, wearing a white women's suit, opened the office door and walked in quickly. She stopped ten centimeters away from the desk and immediately reported the situation to her boss.

"Something happened, boss."

He first said this with a worried face, and then explained in detail without waiting for Ai BoLe to ask.

"The WHO suddenly held a press conference and announced that it would use funds from the foundation to purchase technology licenses from Deepin Technology and provide cancer treatment assistance to some regions."

“In addition, the latest issue of Nature magazine also used Deepin Technology’s new chimeric antigen receptor T cell immunotherapy topic on its cover.”

"This was very detrimental to our company and now the situation has changed."

Paina almost said all these words in one breath, and it could be seen that she was indeed very worried at the moment.

Originally, the boss assigned this task to her, hoping to protect the company's overseas anti-cancer drug market in this way, but this happened and the task failed directly.

It also indirectly caused the company to completely lose the anti-cancer drug market.

She was naturally filled with guilt.

I always feel like I betrayed my boss's trust.

For this reason, as soon as she learned about these situations, she immediately rushed back to the company and went to her boss's office to report to Ai BoLe.

Thinking about whether new measures can be taken to remedy the situation.

Ai BoLe already knew what Paina said, so his expression did not change at all after listening to it.

Always maintain that calm state.

Instead, he pointed to the chair next to him and motioned for Paina to sit down first.

"sit down."

Speaking of which, Paina thought she knew her boss well enough, but facing the current situation, she couldn't help but have a question mark in her mind.

I don’t know why the boss doesn’t seem to take it seriously this time.

You must know that this can be related to the huge interests of the company.

If anti-cancer drugs are eliminated from the market, all the R\u0026D funds they previously invested will be in vain. Crucially, the company will also lose a profitable project in the future.

It stands to reason that when faced with this situation, we should have been anxious and thought of remedial measures.

But seeing that her boss didn't look like he was joking, no matter how confused she felt, she had no choice but to sit down and sit down.

But he did not forget to continue to ask: "Boss, should we take rescue measures again?"

At this time, Ai BoLe was too lazy to show off. Facing Paina's inquiry, he nodded and said, "I already know about this matter. I didn't expect that the WHO would move so quickly."

"Boss, you already know?" Paina exclaimed when she heard the sound.

As soon as she saw the news, she hurried over. Faced with her boss's calm and calm look, she thought that he didn't know the situation yet, so she hurriedly told everything that happened.

In the end, who would have thought that his boss would have known about it for a long time.

"Then what should we do next? Should we contact other pharmaceutical companies to discuss countermeasures together?"

"There's no need for this." Hearing Paina immediately bring the topic back to business, Ai BoLe shook his head in response.

"The impact of the new chimeric antigen receptor T-cell immunotherapy developed by Deepin Technology Bioscience Research Laboratory is beyond our control. The era of anti-cancer drugs is over."

Paina didn't expect that her boss would suddenly be so pessimistic, but she still refused to admit defeat and asked more questions.

"Is there really no other way?"

"Our anti-cancer drugs are inherently incomparable with each other's technology, and now that international organizations have intervened, when the scale of this technology can satisfy the treatment of cancer patients around the world, no one will buy anti-cancer drugs anymore."

"I believe that after today, other pharmaceutical companies will also understand." Ai BoLe added here.

After hearing the boss's words, Paina couldn't help but fall into deep thought.

Thinking about it carefully, they really have no way to deal with it at the moment. It seems that they can only accept it all.

But just when she was silent, Ai BoLe's voice came to her ears again.

"I have a new task for you to do next."

"New mission?" Paina was a little confused.

At this point, she couldn't think of any new tasks that she needed to complete.

Fortunately, her doubts did not last long, and the next second she heard Ai Bo Le continue to speak: "I want to send you to Jingzhou City to strive to reach cooperation with Deepin Technology and obtain their information on new chimeric antigens. Technology authorization for receptor T cell immunotherapy." He spoke with a solemn expression and a serious face, not joking at all.

Paina listened to all Ai Bole's words. When she learned that she was asked to go to Jingzhou City to cooperate with Deepin Technology, her first reaction was that she had heard wrong.

But she soon came to her senses and understood the purpose of her boss's actions.

Now that it is determined that the anti-cancer drug market will no longer exist, we must find new ways for the company's subsequent development.

As for the most promising business in the future, it must be the new chimeric antigen receptor T cell immunotherapy.

The therapeutic effect of anti-cancer drugs is indeed not as good as this therapy, but it is more convenient and can quickly treat a large number of cancer patients.

But the new chimeric antigen receptor T cell immunotherapy will not work.

In any case, no matter how efficient the new chimeric antigen receptor T cell immunity is in the cell modification and expansion process, treatment injections still need to be customized for each patient.

This requires more laboratories that can manufacture such customized injections.

If the new chimeric antigen receptor T-cell immunotherapy wants to be promoted globally, the best way is to license the technology and cooperate with qualified hospital laboratories in various places, allowing these institutions to customize treatment plans for patients, and reduce the global Number of cancers.

Ruihui has a powerful enough laboratory to provide customized treatments for many cancer patients as long as it obtains new chimeric antigen receptor T cell immunotherapy technology.

By then, as long as the cost of treatment is determined, the profits lost in the anti-cancer drug market can be gradually recovered.

As the old saying goes, if you can't beat it, join it.

Paina immediately figured out Ai BoLe's purpose and knew that doing so was the best choice for the company.

However, she was still a little worried and did not immediately accept the boss's task arrangement.

"But based on our relationship with Deepin Technology, will the other party still agree to cooperate with us?"

Her concerns are justified.

Deepin Technology and Ruihui Biotech were obviously in a competitive relationship before, not to mention the methods they used later. To say that Deepin Technology didn't know anything about it is undoubtedly self-deception.

After all, with the level of deep technology in artificial intelligence and quantum computing, it is not difficult to know something.

Under such circumstances, it is normal for Deepin Technology to refuse to cooperate.

They are not the only world-renowned pharmaceutical companies. Deepin Technology can cooperate with others.

Ai Bo Le had no idea about this situation, but in order to help Paina regain her confidence, she had to say a few more words.

"Our cooperation with Deepin Technology is in response to the call of Director-General Tan Said. At that time, we can use the other party's identity to discuss cooperation with Deepin Technology. In addition, we have already joined the Global Quantum Alliance. In a certain sense, we have already cooperated with this talented scientist. There has been cooperation.”

"I believe that the other party will not give up on cooperating with us just because of the previous trivial matter."

After hearing Aibole's words, Paina finally gained some confidence and immediately replied seriously:

"Don't worry, boss, I will definitely do my best to achieve this cooperation."

After saying that, he no longer hesitated and immediately turned around and left to prepare.

In addition, this time it can be said that she has been assigned three important tasks by her boss in a row, but unfortunately the first two tasks were not successful, so this time she can be said to be very determined.

It has to be done no matter what.

…

…

Soon into the new month, as hospitals in big cities such as the imperial capital Yangcheng and Shenzhen announced the official opening of new cancer treatment departments, they were successfully equipped to receive cancer patients, which finally reduced the pressure on Jingzhou a lot.

For this reason, Xu Yun also sent Ding Wei and Zhou Lihua there to ensure that there would be no problems in the early stage of operation.

Although it is still unable to satisfy cancer patients across the country, fortunately, new departments in a new batch of cities are about to open, which will effectively relieve the pressure.

In addition, relying on Tan Said's appeal, overseas regional representatives also came to discuss cooperation.

Hope to get technical authorization from Deepin Technology.

Because this was originally in Xu Yun's plan, he would naturally not refuse it.

The final consensus reached is that every time the other party uses this new technology to treat cancer patients, it needs to deduct a certain percentage from the treatment cost as the technology licensing fee for Deepin Technology.

As for the cost of overseas treatment, that's not his concern.

After all, Deepin's technological capabilities are limited, and he can only ensure that domestic cancer patients can be treated at the lowest cost.

Of course, the cost of treatment here in Jingzhou City is no secret. If the overseas price is too high, others will definitely not agree.

In addition, places that choose to cooperate with Deepin Technology also send personnel to learn technology.

Among them, Tan Said specially sent Bei Luming here.

This shows how much the other party attaches great importance to the grand ideal of completely eradicating cancer.

It is also worth mentioning that Xu Yun is not worried about anyone defaulting on his debt.

Anyway, they are all members of the Global Quantum Alliance. If you really dare to do this, you will be expelled from the Quantum Alliance and you will no longer be able to use the computing power of Zu Chongzhi No. 3 quantum computing.

——

"Let me introduce to you, this is Ms. Paina from Ruihui Biological Company."

“This time I also want to cooperate with Deepin Technology.”

July 3, 2024, Jingzhou City, Longhu Science and Technology Park Biological Research Laboratory Lounge.

Bei Luming first introduced Xu Yun to the identity of the blond woman in front of him, then turned around and said with a smile: "Ms. Paina, this is Mr. Xu Yun, the most genius scientist in mankind who created deep technology."

"I have heard about Mr. Xu Yun's achievements for a long time. Today I am finally lucky enough to meet him in person. I hope that we at Ruihui can also contribute our own strength to the eradication of global cancer." Paina took the initiative to extend her hand and shake Xu Yun's hand. He paused, not hiding the curiosity and passion in his eyes.

After all, facing such a young man full of miracles, I believe no one can control their curiosity.

It seems that Xu Yun is filled with all kinds of secrets, and people can't help but want to find out.

After taking over the task assigned by her boss, Paina made some preparations before taking a plane to Jingzhou.

It is worth mentioning that she did not come to Xu Yun directly, but first approached Bei Luming, a member of the executive committee.

Let the other person act as the introducer.

Bei Luming is naturally aware of the strength of Ruihui Biotechnology. If it can cooperate with Deepin Technology, it will undoubtedly be able to provide customized injection treatments for a large number of cancer patients in a short period of time.

So after he learned about Paina's intention, he agreed to be the introducer without even thinking about it.

At this moment, Xu Yun looked carefully at this powerful working woman and didn't say much.

He was very aware of what Ruihui Creatures had done, but he didn't take it to heart.

It's just for the development of the company, not to mention it has no impact on Deepin Technology.

Therefore, he has nothing against Ruihui Biotechnology coming to seek cooperation.

After inviting a few people to sit down, he said directly: "Ms. Paina should know that we have cooperated with several overseas institutions, so there is nothing to talk about related treaties. If you can accept it, you can sign the contract."

After listening to what Xu Yun said, Paina looked calm on the surface but was actually shocked in her heart.

I didn't expect this trip to go so smoothly.

Some even couldn’t believe it.

Before coming, she rehearsed possible scenarios in her mind more than once.

It even includes making things difficult in deep science and technology.

In this regard, she is also prepared to increase the technology licensing fee and accept some harsh conditions.

In short, cooperation must be achieved no matter what.

In the end, there was no chance that what she was thinking would be put to use, and Xu Yun agreed to cooperate so easily.

Of course she would not blame all of this incident on Bei Luming's face. She could only say that Xu Yun was far different from what she thought.

Under such circumstances, she didn't dare to question, so she naturally expressed her attitude quickly.

"We at Ruihui are willing to accept it."

Xu Yun nodded and said nothing.

Of course, he didn't mean to give Ruihui Biology preferential treatment. The main reason was that the standards for overseas cooperation were the same, and he was too lazy to waste time with Paina on such matters.

With this skill, one can treat a cancer patient.

Although several other major cities now have the ability to use new chimeric antigen receptor T cell immunotherapy to treat patients, which has greatly reduced the pressure on biological research laboratories, Ding Wei and Zhou Lihua are also not in Jingzhou City at the moment, and the experiment He is still responsible for many things in the room.

Also, he felt that the tasks on the panel were almost completed, and he might get the task reward one day.

He was looking forward to this very much.

After confirming Paina's attitude, Xu Yun no longer needs to be involved in the subsequent matters, and can be directly handed over to the company's specialized department to communicate with the other party.

But at this moment, Wang Dong, a research assistant, suddenly ran in.

And he was breathing heavily, obviously running all the way here.

During Xu Yun's time in the laboratory, he basically asked Wang Dong to be his assistant to help out, knowing that Wang Dong was usually relatively steady when doing things.

I suddenly rushed here in a hurry today. There must be something unexpected happening.

His thoughts stayed here without any hesitation, and he quickly asked: "Why are you so anxious? What happened?"

"Xu Yuan."

"Academician Christian suddenly fainted and has been sent to the No. 1 Hospital for treatment."

Faced with Xu Yun's inquiry, Wang Dong took a breath and answered quickly.

"Passed out?"

Hearing Wang Dong mention Christian, Xu Yun quickly stood up from the chair and frowned slightly.

Christian is an academician of the Norwegian Academy of Sciences. His main research field is biological genes. The other party had previously come to Jingzhou City to award him the Abel Prize in Mathematics.

The other party is a relatively kind old man. This time he came here specifically to discuss and learn about the new chimeric antigen receptor T cell immunotherapy.

If something really happened to the other party, it would really be difficult to explain it to the Academy of Sciences where the other party is located.

Thinking of this, Xu Yun no longer hesitated, and immediately turned to Paina next to him and said, "Ms. Paina, I will arrange to meet with you later. I have to deal with an emergency today."

After saying that, he took Wang Dong away and planned to go to the hospital to see how the situation was.

And Bei Lvming obviously knew Christian, and followed closely and said: "I'll go with you."

Soon, when only Paina and her assistant were left in the lounge, the other party seemed to have made some decision, and quickly stood up and followed Xu Yun and Bei Luming.

"We'll go there too."

The cooperation negotiations were going so smoothly, and it was hard for her to stay alone when something like this suddenly happened.

It's better to go with him and earn a good impression.

By the time Xu Yun and others arrived at Jingzhou No. 1 Hospital, Christian had already completed the corresponding examinations, but what made people frown was that it was Lin Yi who was in charge.

It's not that Lin Yi is bad, it's mainly that everyone knows what his presence here as the deputy chief physician of the oncology department means.

With Xu Yun and Lin Yi's familiarity, they naturally would not be restrained at this time and directly asked them about their specific situation.

"How is Academician Christian's health? Has the cause been found out?"

"We have done corresponding examinations, and the final results will not come out for a while, but based on preliminary judgment, it may be liver cancer." Faced with Xu Yun's inquiry, Lin Yi answered truthfully: "And the situation is not optimistic, I'm afraid. It’s already advanced.”

Xu Yun couldn't help but frowned when he heard the result. He didn't expect that the other party actually had cancer.

Liver cancer is relatively easy to treat in its early stages, and there will basically be no major problems even with traditional treatment options.

However, liver cancer is generally not easy to detect in its early stages. By the time it is detected, it is often already in the advanced stage, making the situation very difficult.

But Xu Yun soon cleared these thoughts from his mind.

Anyway, with the new chimeric antigen receptor T-cell immunotherapy technology, there is still a good chance of curing Christian.

It's just that Christian came here mainly to study the physical changes of patients after using this technology, and now he has become a research subject.

I don't know if this is a good thing or a bad thing for him.

"Then let's wait for the results to come out."

Xu Yun thought for a moment and decided to wait for the test results to confirm Christian's true condition before telling the other party about it.

With Lin Yi's help, they didn't have to wait long, and the inspection report was uploaded to the hospital system soon.

And just as Lin Yi judged, Christian did have liver cancer and it was quite serious.

After getting the results, Xu Yun didn't waste any time and arrived at Christian's ward.

"Academician Christian, I have good news and bad news here. Which one do you want to hear first?"

Looking at Christian who was already sitting up on the hospital bed, Xu Yun wanted to liven up the atmosphere and said this.

Although Christian's hair was already silvery white and was combed completely behind his ears to reveal his shiny forehead, his temperament was not at all like that of an old man.

After hearing what Xu Yun said, he immediately became interested and made a cooperative choice.

"Hear the bad news first."

"The bad news is that you have just been diagnosed with liver cancer. Here is the test report."

Xu Yun didn't bother to be tactful, he told the matter directly and handed the inspection report to the other party.

But before the other party could choose another piece of news, he smiled and said: "The good news is that it can be treated with the technology of our laboratory, so please rest assured, Academician Christian."

After experiencing such completely different news, everyone thought that Christian would be at a loss, but the next second he shouted excitedly.

"It's just awesome."

"Xu."

"I hope to be able to perform the treatment in a laboratory, which will allow me to better record the body's changes and reactions."

His whole face was full of joy, and he was not worried at all about being diagnosed with cancer.

Paina, who followed and saw this scene, also understood why Deepin Technology's new chimeric antigen receptor T cell immunotherapy is the future trend.

Facing a relatively serious liver cancer patient, he was still able to carry out treatment with confidence, which is something that their Ruihui anti-cancer drug cannot do.

…